Merck & Co to buy $1bn stake in Seattle Genetics
16-09-2020
Partial win for Mylan as Fed Circuit cancels Boehringer patents
17-03-2020
nitpicker / Shutterstock.com
The Federal Court of Australia has rejected Boehringer Ingelheim’s animal health unit's attempt to stop the registration of a patent owned by Intervet International on various grounds.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Boehringer Ingelheim, Intervet International, Merck & Co, patent registration, animal health, Federal Court of Australia, parasites
